1. Home
  2. ALZN vs HIHO Comparison

ALZN vs HIHO Comparison

Compare ALZN & HIHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALZN
  • HIHO
  • Stock Information
  • Founded
  • ALZN 2016
  • HIHO 1990
  • Country
  • ALZN United States
  • HIHO Hong Kong
  • Employees
  • ALZN N/A
  • HIHO N/A
  • Industry
  • ALZN Medicinal Chemicals and Botanical Products
  • HIHO Industrial Machinery/Components
  • Sector
  • ALZN Health Care
  • HIHO Industrials
  • Exchange
  • ALZN Nasdaq
  • HIHO Nasdaq
  • Market Cap
  • ALZN 7.5M
  • HIHO 7.6M
  • IPO Year
  • ALZN 2021
  • HIHO 1996
  • Fundamental
  • Price
  • ALZN $2.32
  • HIHO $1.63
  • Analyst Decision
  • ALZN Strong Buy
  • HIHO
  • Analyst Count
  • ALZN 1
  • HIHO 0
  • Target Price
  • ALZN $45.00
  • HIHO N/A
  • AVG Volume (30 Days)
  • ALZN 71.9K
  • HIHO 12.6K
  • Earning Date
  • ALZN 09-10-2025
  • HIHO 10-09-2025
  • Dividend Yield
  • ALZN N/A
  • HIHO 7.34%
  • EPS Growth
  • ALZN N/A
  • HIHO N/A
  • EPS
  • ALZN N/A
  • HIHO 0.02
  • Revenue
  • ALZN N/A
  • HIHO $7,412,000.00
  • Revenue This Year
  • ALZN N/A
  • HIHO N/A
  • Revenue Next Year
  • ALZN N/A
  • HIHO N/A
  • P/E Ratio
  • ALZN N/A
  • HIHO $81.73
  • Revenue Growth
  • ALZN N/A
  • HIHO 17.26
  • 52 Week Low
  • ALZN $2.06
  • HIHO $1.40
  • 52 Week High
  • ALZN $22.23
  • HIHO $2.88
  • Technical
  • Relative Strength Index (RSI)
  • ALZN 40.27
  • HIHO 46.31
  • Support Level
  • ALZN $2.34
  • HIHO $1.66
  • Resistance Level
  • ALZN $2.53
  • HIHO $1.70
  • Average True Range (ATR)
  • ALZN 0.13
  • HIHO 0.06
  • MACD
  • ALZN 0.02
  • HIHO -0.00
  • Stochastic Oscillator
  • ALZN 29.03
  • HIHO 12.30

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

About HIHO Highway Holdings Limited

Highway Holdings Ltd is a holding company. Along with its subsidiaries, it operates as a fully integrated manufacturer of high-quality metal, plastic, electric and electronic components, subassemblies, and finished products for OEMs and contract manufacturers. The manufacturing services offered by the group include metal stamping, screen printing, plastic injection molding, pad printing, and electronic assembly of printed circuit boards. Its reportable business segments are metal stamping and mechanical OEM operations, which derive maximum revenue, and electric OEM operations. Geographically, the group generates maximum revenue from Europe, and the rest from North America, Hong Kong and China, and other Asian countries.

Share on Social Networks: